Chuck Mikolajczak, Reuters
NEW YORK — U.S. stocks fell in a broad selloff on Tuesday, dropping for a second straight session and driving the Dow below 17,000 as investors turned cautious before the start of earnings season. The benchmark S&P 500 index, however, recovered from earlier lows and managed to hold near its 14-day moving average of 1,964.61. That would be a sign of weak near-term momentum if the S&P 500 declined below that level by a significant amount. Nine of the 10 primary S&P 500 sector indexes declined, with only the defensive utilities group higher for the day. U.S.
NEW YORK — U.S. stocks dipped on Monday, retreating from last week’s record levels as investors hesitated to make big bets before the start of earnings season. Cyclical stocks, which are tied to the pace of economic growth, ranked among the weakest of the day. The S&P industrial sector index fell 0.7 percent. The only sectors finishing the session on the plus side were defensive groups such as utilities, up 0.4 percent, telecom, up 0.3 percent and consumer staples, up 0.1 percent. Small-cap stocks also underperformed, with the S&P Small-Cap 600 index down 1.5 percent.
NEW YORK — U.S. stocks fell on Tuesday as early enthusiasm from economic data faded and concerns about the violence in Iraq gave investors a reason to sell and book some profits, driving the Dow to its biggest drop in over a month. In the latest signs of improving economic conditions, consumer confidence surged more than expected in June, while new home sales in May rose more than anticipated.
NEW YORK — The Dow and the S&P 500 edged up to end at record highs on Friday, wrapping up four straight months of gains, after mixed economic data gave investors little reason to rush into stocks. After the benchmark S&P 500’s latest record closing high — its fourth in the last five sessions —gains may be harder to come by until the market’s direction becomes more clear. Payrolls data and a European Central Bank meeting will be the major catalysts next week. U.S.
NEW YORK — The S&P 500 index climbed to its third record-closing high in four sessions on Thursday as traders shrugged off data that showed the economy shrank in the first quarter and bet on improvement in the second quarter. New claims for unemployment benefits fell more than expected last week, pointing to a strengthening labor market and giving investors a reason to buy U.S. stocks.
NEW YORK — U.S. stocks dropped on Friday, pulled lower by a selloff in consumer discretionary stocks as bellwether names Amazon.com and Ford Motor fell in the wake of their quarterly earnings. Amazon was the S&P 500’s worst performer, down 9.9 percent to $303.83, and other high-flying sectors dropped along with it. Social media names slid, with Twitter losing 7.1 percent to $41.61, and the Nasdaq Biotechnology Index falling 2.4 percent as investors once again shied away from riskier sectors.
NEW YORK — The Nasdaq rose modestly in a choppy session on Thursday, lifted by a rally in Apple shares a day after the iPadmaker’s strong results, though tensions in Ukraine held the broader market in check. Shares of Apple Inc., the most valuable U.S. company by market capitalization, jumped 8.2 percent to $567.77, the biggest gain since August, a day after the company posted revenue that far outpaced expectations.
NEW YORK — U.S. stocks advanced modestly on Monday in subdued trading as investors showed hesitation in the wake of a strong rally last week and before a slew of key earnings releases this week. Monday’s gain marked the S&P 500’s fifth straight climb, its longest winning streak since October. The S&P 500 wrapped up its best week since July last week, boosted by results from such names as General Electric Co.
NEW YORK — U.S. stocks slipped on Friday, as investors booked profits in momentum names heading into the weekend, wiping out early gains that had pushed the S&P 500 to an intraday record high. The S&P 500 lost momentum after hitting an all-time intraday high of 1,883.97, with biotechs among the primary decliners. Biogen Idec Inc., down 8.2 percent at $318.53, and Gilead Sciences Inc., down 4.6 percent at $72.07, were the two biggest drags on the S&P 500. The Nasdaq biotech index fell 4.4 percent. U.S.
NEW YORK — U.S. stocks rose on Thursday, after a batch of economic data pointed to an improving economy and investors reassessed Fed Chair Janet Yellen’s comments that had fueled speculation of an earlier-than-expected rate hike by the central bank. After several weeks of soft economic data attributed by many investors to harsh winter weather conditions, labor market data on Thursday showed the number of Americans filing for jobless benefits hovered near three-month lows last week.